Please assess the completion status of the following clinical trial:

Trial Title: Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female adults aged 65 years or older on the day of vaccination and able to fulfill study requirements.~Exclusion Criteria:~* Previous vaccination with any licensed or experimental pneumococcal vaccine~* Residence in a nursing home, long-term care facility, or similar facility~* Known hypersensitivity to vaccination~* Immune deficiency or suppression

- Gender: ALL
- Minimum Age: 65 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): None
- 13-valent pneumococcal conjugate vaccine (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).